Escitalopram in Schizophrenia in OCD- Open Label Study

Phase 4

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00456937
• Lead Sponsor: BeerYaakov Mental Health Center

Brief Summary

SSRI's has been demonstrated to be partially effective in schizophrenia and OCD. We therefore suggest that Escitalopram up to 20 mg /d in those patients could be effective in reducing obsessive compulsive symptomatology

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07
• Study First Submitted: 2006-12-03
• Study First Submitted QC: 2007-04-04
• Study First Posted: 2007-04-05
• Primary Completion: 2008-09
• Study Completion: 2008-09
• Status Verified: 2009-01
• Last Update Submitted: 2009-01-26
• Last Update Posted: 2009-01-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

• Patients who suffer from schizophrenia and OCD

Exclusion Criteria

• Substance abuse,
• Serious medical condintions,
• Being on SSRI treatment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

Beer Yaakov MHC; 🇮🇱 Beer Yaakov, Israel

Beer Yaakov MHC

🇮🇱Beer Yaakov, Israel